申请人:Chesworth Richard
公开号:US20110224204A1
公开(公告)日:2011-09-15
Di-substituted phenyl compounds which are inhibitors of phosphodiesterase 10 are described as are processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of mammals, including human(s) for central nervous system (CNS) disorders and other disorders which may affect CNS function. The disclosure also relates to methods for treating neurological, neurodegenerative and psychiatric disorders including but not limited to those comprising cognitive deficits or schizophrenic symptoms.
本文描述了抑制磷酸二酯酶10的双取代苯化合物,以及这些化合物在治疗哺乳动物,包括人类的中枢神经系统(CNS)疾病和其他可能影响CNS功能的疾病中的制备方法、制药组合物、制药制剂和制药用途。此外,本文还涉及治疗神经、神经退行性和精神障碍的方法,包括但不限于那些包括认知缺陷或精神分裂症状的方法。